2007Medical Journal of Chinese People's HealthRequires access

Two citalopram in the treatment of depressive patients

Jiong Chen

Open publisher page 0 citations

Abstract

Objective:To compare efficacy and side effects of two citalopram in the treatment of patients with schizophrenia. Methods:80 patients meeting depression criterion in CCMD-3 were simdomly divided into group A(xipumiao) and group B(xitaile),and observed for 8 weeks.Results: Two groups have significant changes in symptoms,but no differences in efficacy and side effects was found between two groups except great efficacy in sleep of group B in second weekend.Conclusions: The efficacy of two citalopram in the treatment of depressive patients is good.

About this research paper

What this paper is about

Objective:To compare efficacy and side effects of two citalopram in the treatment of patients with schizophrenia. Methods:80 patients meeting depression criterion in CCMD-3 were simdomly divided into group A(xipumiao) and group B(xitaile),and observed for 8 weeks.Results: Two groups have significant changes in symptoms,but no differences in efficacy and side effects was found between two groups except great efficacy in sleep of group B in second weekend.Conclusions: The efficacy of two citalopram in the treatment of depressive patients is good.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To compare efficacy and side effects of two citalopram in the treatment of patients with schizophrenia. Methods:80 patients meeting depression criterion in CCMD-3 were simdomly divided into group A(xipumiao) and group B(xitaile),and observed for 8 weeks.Results: Two groups have significant changes in symptoms,but no differences in efficacy and side effects was found between two groups except great efficacy in sleep of group B in second weekend.Conclusions: The efficacy of two citalopram in the treatment of depressive patients is good.

Key concepts: Citalopram, Depression (economics), Schizophrenia (object-oriented programming), Medicine, Internal medicine, Depressive symptoms, Clinical efficacy, Side effect (computer science)

Related papers

Back to paper searchBrowse research topicsOriginal source
Two citalopram in the treatment of depressive patients — Research Paper | ScholarLens